Neoadjuvant or Adjuvant Chemotherapy for Breast Cancer in Sub-Saharan Africa: A Retrospective Analysis of Recurrence and Survival in Women Treated for Breast Cancer at the Korle Bu Teaching Hospital in Ghana | Zendy

Hannah Ayettey Anie | Zendy; Joel Yarney | Zendy; Olutobi Adekunle Sanuade | Zendy; Shivanshu Awasthi | Zendy; Tom Akuetteh Ndanu | Zendy; Akash D. Parekh | Zendy; Charles Aidoo | Zendy; Mary Ann Dadzie | Zendy; Verna Vanderpuye | Zendy; Kosj Yamoah | Zendy

Open Access

Neoadjuvant or Adjuvant Chemotherapy for Breast Cancer in Sub-Saharan Africa: A Retrospective Analysis of Recurrence and Survival in Women Treated for Breast Cancer at the Korle Bu Teaching Hospital in Ghana

Author(s) -

Hannah Ayettey Anie,

Joel Yarney,

Olutobi Adekunle Sanuade,

Shivanshu Awasthi,

Tom Akuetteh Ndanu,

Akash D. Parekh,

Charles Aidoo,

Mary Ann Dadzie,

Verna Vanderpuye,

Kosj Yamoah

Publication year - 2021

Publication title -

jco global oncology

Language(s) - English

Resource type - Journals

ISSN - 2687-8941

DOI - 10.1200/go.20.00664

Subject(s) - medicine , breast cancer , hazard ratio , oncology , chemotherapy , odds ratio , retrospective cohort study , proportional hazards model , cancer , radiation therapy , surgery , confidence interval

It is established that addition of systemic therapy to locoregional treatment for breast cancer improves survival. However, reliable data are lacking about the outcomes of such treatment in women with breast cancer in low middle-income countries. We compared the outcomes of treatment in patients who had received neoadjuvant chemotherapy (NACT) or adjuvant chemotherapy and examined the factors associated with breast cancer recurrence and survival at the National Radiotherapy Oncology and Nuclear Medicine Centre, Korle Bu Teaching Hospital, Ghana.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research